Skip to content
The Nexus
DossierENTITY

Johns Hopkins Center for Health Security

Coverage of Johns Hopkins Center for Health Security in the Nexus archive.

Earliest in view: May 8 · 14:39 UTCMost recent: May 11 · 16:38 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHMay 11 · 16:38 UTCABC NEWS
    WATCH: Your questions about the deadly hantavirus answered

    Dr. Amesh Adalja explains the Andes variant of the hantavirus and how it spreads. The hantavirus is a deadly virus that has raised concerns. Dr. Adalja is a senior scholar at Johns Hopkins Center for Health Security.

  • HEALTHMay 8 · 14:39 UTCTHE INTERCEPT
    Amid Hantavirus Panic, the Ivermectin Super Fans Are Back

    Prominent Covid-era ivermectin advocates are promoting the drug as a potential treatment for hantavirus despite lack of clinical evidence. The Andes hantavirus outbreak has sparked concerns and misinformation about ivermectin's effectiveness. Health experts emphasize that there is no meaningful clinical evidence supporting ivermectin's use against hantaviruses.

Johns Hopkins Center for Health Security · Dossier · The Nexus